JNHM.F Stock Overview
Operates primary care medical clinics in Walmart Supercentres under the Jack Nathan Health brand name in Canada and Mexico.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Jack Nathan Medical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.033 |
| 52 Week High | CA$0.061 |
| 52 Week Low | CA$0.017 |
| Beta | -1.39 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -40.15% |
| 33 Year Change | -86.55% |
| 5 Year Change | n/a |
| Change since IPO | -97.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| JNHM.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | n/a | 0.2% | 0.9% |
| 1Y | -40.1% | 12.2% | 32.4% |
Return vs Industry: JNHM.F underperformed the US Healthcare industry which returned 9.7% over the past year.
Return vs Market: JNHM.F underperformed the US Market which returned 32.1% over the past year.
Price Volatility
| JNHM.F volatility | |
|---|---|
| JNHM.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: JNHM.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine JNHM.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Glenn Copeland | www.jacknathanhealth.com |
Jack Nathan Medical Corp., together with its subsidiaries, operates primary care medical clinics in Walmart Supercentres under the Jack Nathan Health brand name in Canada and Mexico. It operates clinics, Rehab, and MedSpa. The company was founded in 2006 and is headquartered in Woodbridge, Canada.
Jack Nathan Medical Corp. Fundamentals Summary
| JNHM.F fundamental statistics | |
|---|---|
| Market cap | US$2.26m |
| Earnings (TTM) | -US$5.75m |
| Revenue (TTM) | US$14.96m |
0.2x
P/S Ratio-0.4x
P/E RatioIs JNHM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JNHM.F income statement (TTM) | |
|---|---|
| Revenue | CA$20.20m |
| Cost of Revenue | CA$4.99m |
| Gross Profit | CA$15.21m |
| Other Expenses | CA$22.98m |
| Earnings | -CA$7.77m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.089 |
| Gross Margin | 75.31% |
| Net Profit Margin | -38.46% |
| Debt/Equity Ratio | -156.0% |
How did JNHM.F perform over the long term?
See historical performance and comparison